The meeting will bring together Small Animal Imaging Facility Directors and Managers who are experts across all major imaging modalities. The goal since the inception of the MPIC continues to be facilitating an open dialogue between facility labs and industry partners, each who share the complementary goal of advancing translational science through preclinical imaging.
This presentation will introduce magnetic particle imaging (MPI) and current applications in preclinical imaging. MPI is the first molecular imaging technique simultaneously capable of: nanomolar sensitivity, absolute quantitation, resolution independent of depth, and with tracer detection from weeks to months. MPI is complementary to existing molecular imaging techniques, giving scientists a new versatile tool to accelerate cancer, infectious disease, cell tracking, and vascular research.
This presentation will introduce a ground-breaking, next generation imaging technology called magnetic particle imaging (MPI). We will review the basic theory behind MPI along with current and future application opportunities.
MPI is a revolutionary technique for imaging iron oxide tracers with high sensitivity and contrast. This presentation will be co-hosted by Magnetic Insight and LodeSpin Labs.
LodeSpin Labs is developing a suite of high-performance MPI-optimized nanoparticles. These unique nanoparticles start as iron oxide cores for maximum SNR and resolution. Added functional, biocompatible coatings extend blood circulation and support conjugation chemistry for a variety of applications. LS-008, LodeSpins Lab’s blood pool tracer, circulates for hours in mice, greatly enhancing the MPI imaging window and improving SNR and resolution compared with standard SPIO tracers.
Additionally, Magnetic Insight will discuss the versatility of available SPIO’s to support applications in cell tracking, functional targeting and interventional imaging.